healthy choice glp-1 Conagra introduces badges on select items, leading consumers to GLP-1-friendly options Eating Healthy Choice Simply Steamers

Pull the plunger back to release the correct dosage of B12 solution into the syringe

The outcome no one measured (until recently) The most striking finding from the Batsis review: among 36 primary studies, none reported objective physical function outcomes

The proportion of patients with a Week 26 value achieving HbA1c of less than 7% at Week 26 were 57% and 48% for BYDUREON and insulin glargine, respectively

The authors concluded: The use of GLP-1 agonists should be considered in T1DM patients who are overweight or obese and not at glycemic goals despite aggressive insulin therapy. After conducting clinical trials with a GLP-1 agonist, Novo Nordisk decided not to pursue FDA approval for treating type 1 diabetes

GP and bariatric physician Lara Courtenay, a MAS Member who works with the Weightless specialist team at Aucklands MacMurray Centre, says the dialling down of food noise gives people the space to explore the underlying issues of their obesity